Bristol-Myers Squibb Co
BMV:BMY
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
789
1 261
|
| Price Target |
|
We'll email you a reminder when the closing price reaches MXN.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one
BMY
stock under the Base Case scenario is
hidden
MXN.
Compared to the current market price of 953.4 MXN,
Bristol-Myers Squibb Co
is
hidden
.
Valuation History
Bristol-Myers Squibb Co
BMY looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if BMY is one of them.
Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Bristol-Myers Squibb Co.
Fundamental Analysis
BMY Profitability Score
Profitability Due Diligence
Score
BMY Solvency Score
Solvency Due Diligence
Score
Select up to 3 indicators:
Select up to 3 indicators:
Heightened patent-expiration risk and revenue concentration around key drugs like Revlimid and Eliquis could sharply reduce Bristol-Myers Squibb’s cash flows, limiting its ability to fund pipeline development.
Bristol-Myers Squibb holds a leading position in immuno-oncology with proven blockbusters like Opdivo and Yervoy, providing a strong base of recurring revenue and brand recognition.
Revenue & Expenses Breakdown
Bristol-Myers Squibb Co
Balance Sheet Decomposition
Bristol-Myers Squibb Co
Bristol-Myers Squibb Co
Free Cash Flow Analysis
Bristol-Myers Squibb Co
| USD | |
| Free Cash Flow | USD |
Earnings Waterfall
Bristol-Myers Squibb Co
Wall St
Price Targets
BMY Price Targets Summary
Bristol-Myers Squibb Co
According to Wall Street analysts, the average 1-year price target for
BMY
is 1 000.73 MXN
with a low forecast of 587.85 MXN and a high forecast of 1 255.49 MXN.
Dividends
Current shareholder yield for
BMY is
hidden
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
BMY
stock under the Base Case scenario is
hidden
MXN.
Compared to the current market price of 953.4 MXN,
Bristol-Myers Squibb Co
is
hidden
.